Association of LI-RADS and Histopathologic Features with Survival in Patients with Solitary Resected Hepatocellular Carcinoma

医学 肝细胞癌 危险系数 比例危险模型 倾向得分匹配 回顾性队列研究 磁共振成像 生存分析 置信区间 放射科 胃肠病学 内科学
作者
Roberto Cannella,Francesco Matteini,Marco Dioguardi Burgio,Riccardo Sartoris,Aurélie Beaufrère,Julien Caldéraro,Sebastien Mulé,Édouard Reizine,Alain Luciani,Alexis Laurent,Olivier Séror,Nathalie Ganne‐Carriè,Mathilde Wagner,Olivier Scatton,Valérie Vilgrain,François Cauchy,Christian Hobeika,Maxime Ronot
出处
期刊:Radiology [Radiological Society of North America]
卷期号:310 (2): e231160-e231160 被引量:16
标识
DOI:10.1148/radiol.231160
摘要

Background Both Liver Imaging Reporting and Data System (LI-RADS) and histopathologic features provide prognostic information in patients with hepatocellular carcinoma (HCC), but whether LI-RADS is independently associated with survival is uncertain. Purpose To assess the association of LI-RADS categories and features with survival outcomes in patients with solitary resected HCC. Materials and Methods This retrospective study included patients with solitary resected HCC from three institutions examined with preoperative contrast-enhanced CT and/or MRI between January 2008 and December 2019. Three independent readers evaluated the LI-RADS version 2018 categories and features. Histopathologic features including World Health Organization tumor grade, microvascular and macrovascular invasion, satellite nodules, and tumor capsule were recorded. Overall survival and disease-free survival were assessed with Cox regression models. Marginal effects of nontargetoid features on survival were estimated using propensity score matching. Results A total of 360 patients (median age, 64 years [IQR, 56-70 years]; 280 male patients) were included. At CT and MRI, the LI-RADS LR-M category was associated with increased risk of recurrence (CT: hazard ratio [HR] = 1.83 [95% CI: 1.26, 2.66], P = .001; MRI: HR = 2.22 [95% CI: 1.56, 3.16], P < .001) and death (CT: HR = 2.47 [95% CI: 1.72, 3.55], P < .001; MRI: HR = 1.80 [95% CI: 1.32, 2.46], P < .001) independently of histopathologic features. The presence of at least one nontargetoid feature was associated with an increased risk of recurrence (CT: HR = 1.80 [95% CI: 1.36, 2.38], P < .001; MRI: HR = 1.93 [95% CI: 1.81, 2.06], P < .001) and death (CT: HR = 1.51 [95% CI: 1.10, 2.07], P < .010) independently of histopathologic features. In matched samples, recurrence was associated with the presence of at least one nontargetoid feature at CT (HR = 2.06 [95% CI: 1.15, 3.66]; P = .02) or MRI (HR = 1.79 [95% CI: 1.01, 3.20]; P = .048). Conclusion In patients with solitary resected HCC, LR-M category and nontargetoid features were negatively associated with survival independently of histopathologic characteristics. © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Kartalis and Grigoriadis in this issue.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
congjia完成签到,获得积分10
1秒前
1秒前
要减肥涔完成签到,获得积分10
1秒前
2秒前
2秒前
111111完成签到 ,获得积分10
2秒前
cll完成签到 ,获得积分10
3秒前
3秒前
科研通AI6.2应助r93527005采纳,获得50
3秒前
3秒前
娜娜子欧发布了新的文献求助10
3秒前
fanfan发布了新的文献求助10
4秒前
小谢发布了新的文献求助10
4秒前
紧张完成签到,获得积分10
5秒前
我是老大应助钦钦采纳,获得10
5秒前
丘比特应助科研领军人物采纳,获得10
5秒前
传奇3应助PA采纳,获得10
5秒前
5秒前
6秒前
Rachel发布了新的文献求助10
6秒前
6秒前
淡然初瑶完成签到 ,获得积分10
6秒前
7秒前
7秒前
7秒前
7秒前
鲤鱼纸飞机完成签到,获得积分10
8秒前
8秒前
8秒前
8秒前
zh发布了新的文献求助10
8秒前
9秒前
酷炫葵阴发布了新的文献求助10
9秒前
爆米花应助Mars-philosopher采纳,获得10
10秒前
个性的立诚完成签到,获得积分20
10秒前
kapuxinxin发布了新的文献求助10
10秒前
nibaba发布了新的文献求助30
10秒前
沙司利益完成签到 ,获得积分20
10秒前
小耗子发布了新的文献求助10
11秒前
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Principles of town planning: translating concepts to applications 1000
2016 Venous Blood Study (VBS) (Final V3.0) 510
Management and the Arts 510
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
The Effective Clinical Neurologist 3ed 500
The Great Hymn to Šamaš 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7699249
求助须知:如何正确求助?哪些是违规求助? 9258613
关于积分的说明 20015018
捐赠科研通 7274361
什么是DOI,文献DOI怎么找? 3293431
关于科研通互助平台的介绍 2448864
邀请新用户注册赠送积分活动 2299727